Search for Clinical Trial Results

Hemolysis - 12 Studies Found
Status | Study |
Completed |
Study Name: Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty Condition: Hemolysis Date: 2008-11-17 Interventions: Drug: Propofol Patients in the Propofol Group (PG) will be induced with target-controlled infusion (TCI) |
Completed |
Study Name: Investigating the Influence of Haemolysis on the Potassium Concentration After Capillary Blood Sampling Condition: Hemolysis Date: 2015-11-24 Interventions:
|
Completed |
Study Name: Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department. Condition:
Date: 2016-11-24 Interventions: Device: Hemolysis Point-of-Care test Hemolysis measurement of plasma using a point of care test to deter |
Completed |
Study Name: Isoagglutinins in the Development of IVIG-associated Hemolysis Condition:
Date: 2014-08-29 |
Completed |
Study Name: Hemolysis in Patients With Hereditary Spherocytosis (HS) Condition:
Date: 2010-09-12 Interventions: Other: fermented papaya preparation (FPP) Hemolysis will be assayed by suspending 3 ml of packed RBC in |
Not yet recruiting |
Study Name: Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease Condition: Haemolysis Neonatal Date: 2017-04-24 Interventions: Drug: intravenous immunoglobulin giving intravenous immunoglobulin to neonates included in inclusion cri |
Completed |
Study Name: R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions Condition: Hemolysis Date: 2012-03-16 |
Completed |
Study Name: An Open Label Study of the Effects of Eculizumab in CD59 Deficiency Condition: Chronic Hemolysis Date: 2012-02-23 Interventions: Drug: Eculizumab PNH and or atypical TTP classical protocols |
Not yet recruiting |
Study Name: A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) Condition: Date: 2025-08-02 |
Completed |
Study Name: Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 Condition:
Interventions: Other: HUS standard coverage care (including in ICU) HUS standard coverage care : plasmaphereses - eculi |